Might Depression Be Linked to One of These Popular Medications?
If you’re taking beta blockers, certain kinds of anxiety drugs, certain types of painkillers (including ibuprofen), proton pump inhibitors (PPIs) (used to treat acid reflux), ACE inhibitors (used to treat high blood pressure), or anti-convulsant drugs, you may be at greater risk for depression. That’s according to a new, large-scale study published earlier this week in JAMA. However, this was a correlational study, so it can’t say that these medications actually cause depression or not. It may be that people with greater health problems are more likely to take one of these medications and be depressed abo...
Source: World of Psychology - June 15, 2018 Category: Psychiatry & Psychology Authors: John M. Grohol, Psy.D. Tags: Depression General Medications Psychiatry Research Drugs cause depression popular medications Source Type: blogs

Top 25 Psychiatric Medications for 2016
Most people understand that the role of psychiatric medications is to help alleviate the symptoms associated with different types of mental disorders, such as depression, bipolar disorder, ADHD, schizophrenia, anxiety, and more. Psychiatric medications are an important part of a comprehensive treatment plan for effectively treating people who have a mental health concern or mental illness. It’s good to know what drugs are being most-often prescribed for mental disorders in the U.S. These are the top 25 psychiatric medications by number of U.S. prescriptions dispensed in 2016, according to QuintilesIMS, a global infor...
Source: World of Psychology - October 12, 2017 Category: Psychiatry & Psychology Authors: John M. Grohol, Psy.D. Tags: General Medications Psychiatry Treatment medications for mental illness Psychiatric Drugs Psychiatric Medications psychiatric meds top psychiatric medications Source Type: blogs

Medications that Increase the Risks of Falling
Falls are the leading cause of both fatal and non-fatal injuries for adults 65 and older, and research suggests that those taking four or more medications are at an even greater risk than those who don ’t.ByAlzheimer's Reading RoomWhat ’s the Difference Between Alzheimer’s and DementiaHow to Test Your Memory for Alzheimer's and DementiaHow to Get Answers To Your Questions About Alzheimer's and Dementia“Falls are the leading cause of both fatal and non-fatal injuries for adults 65 and older, and research suggests that those taking four or more medications are at an even greater risk than those who do...
Source: Alzheimer's Reading Room, The - February 1, 2017 Category: Neurology Tags: alzheimer's care care of dementia patients dementia care health help alzheimer's help with dementia care medications falls Prescription Medications Risks risk of falling senior care Source Type: blogs

Antidepressants And Women ’s Bones
Certain antidepressants used to relieve hot flashes, night sweats and other menopausal symptoms appear to increase the risk of bone fractures. The class of drugs, selective serotonin reuptake inhibitors (SSRIs), include Celexa, Lexapro, Prozac, Luvox, Paxil and Zoloft, and are now considered effective alternatives to hormone replacement therapy. Investigators from Boston’s Northeastern University used a pharmaceutical database to identify more than 137,000 women age 40 through 64 who began taking SSRIs for menopausal symptoms between 1998 and 2010 and compared them with some 236,000 women taking prescription drugs fo...
Source: Dr. Weil's Daily Health Tips - November 1, 2016 Category: Consumer Health News Authors: Dr. Weil Tags: Science and Supplement News antidepressant bone density bones Source Type: blogs

Dementia Care, Which Drugs Increase the Risk of Falling
Medications can increase the risk of falls and falling; and, are a major cause of injuries and death in older adults.By Bob DeMarcoAlzheimer's Reading RoomDuring the entire 8 and a half years, 3,112 days, that I was taking care of my mother, I worried about her falling.Falls can result in hip injuries, head injuries, or something worse.If you loved one is falling, or complaining of "dizziness" check out the list of medications below; and then, consult with your personal care doctor.Problems with Balance, Walking, Falling an Early Sign of DementiaThe drugs older people take can make them more susceptible to fallin...
Source: Alzheimer's Reading Room, The - September 7, 2016 Category: Neurology Tags: alzheimer's care Alzheimer's Dementia dementia care dementia falls dementia help for caregivers family caregiving help alzheimer's help with dementia care memory care searches related to falling Source Type: blogs

Alzheimer's Care Sex and Dementia
The increased sexual behavior may be one way persons living with Alzheimer's and dementia try to communicate.Dr. Rita Jablonski-JaudonAlzheimer's Reading RoomSexuality is a topic that is not often encountered here in the ARR, but I wanted to broach it after receiving an email from a reader. Her husband has AD and continues to become deeply forgetful, moving backward in time.In his world, they are young newlyweds and he wishes to shower his lovely wife with physical affection. He asks her several times a day to join him in the bedroom.Coping with DementiaSubscribe to the Alzheimer's Reading Room Email: At night, he invites ...
Source: Alzheimer's Reading Room, The - July 18, 2016 Category: Neurology Tags: alzheimer awareness alzheimer communication alzheimers care alzheimers caregiving dementia help for caregivers family caregiving help alzheimer's help with dementia help with dementia care Source Type: blogs

Corruption of clinical trials reports: a proposal
CORRUPTION OF CLINICAL TRIALS REPORTS:A PROPOSALThere is a disconnection between the FDA’s drug approval process and the reports we see in medical journals. Pharmaceutical corporations exploit this gap through adulterated, self-serving analyses, and the FDA sits on its hands. I suggest we need a new mechanism to fix the problem – by independent analyses of clinical trials data.When they analyze and publish their clinical trials in medical journals, pharmaceutical corporations have free rein to shape the analyses. The FDA conducts independent analyses of the data submitted by the corporations, and it may deny or...
Source: Health Care Renewal - June 22, 2016 Category: Health Management Tags: Bernard Carroll citalopram clinical trials Eric Topol escitalopram FDA Forest Pharmaceuticals Jay Amsterdam Jon Jureidini Leemon McHenry Lisa Cosgrove Lundbeck Underwriters Laboratory vortioxetine Source Type: blogs

Longing for the QT
A 58-year-old man presented to the ED with a reported overdose of an unknown medication. The patient was agitated, combative, and altered. Initial vital signs included a heart rate of 115 beats/min, blood pressure of 154/93 mm Hg, respirations of 22/min, and temperature of 99.5°F. The patient was difficult to evaluate because he was agitated, and he was given 5 mg of haloperidol IV and 2 mg of lorazepam IV. The patient continued to be agitated, and was given another 10 mg of haloperidol IV, followed by a repeat dose of 10 mg IV 15 minutes later. The patient then became unresponsive, and his cardiac monitor demonstrated...
Source: The Tox Cave - March 1, 2016 Category: Emergency Medicine Tags: Blog Posts Source Type: blogs

Their Cheating Hearts - Latest Allergan Settlement Is a Reminder of Merger Participants' Sketchy Pasts
A Huge, but Sketchy Merger The announced merger and "tax inversion" of Pfizer and Allergan would be one of the largest corporate marriages in US history.  It has drawn more than its share of criticism.  For example, per the Los Angeles Times, former US Senator and Secretary of State, and current presidential candidate Hilary Clinton said "this proposed merger, and so-called inversions by other companies, will leave U.S. taxpayers holding the bag." By creating the world's largest drug company, it could certainly further consolidate the US and global pharmaceutical market and raise already high ...
Source: Health Care Renewal - November 24, 2015 Category: Health Management Tags: Allergan crime deception fraud impunity kickbacks legal settlements obstruction of justice Pfizer RICO Source Type: blogs

Does Insurance Cover Botox Injections for Migraine Headaches?
Unfortunately no insurance company covers Botox therapy for generic headaches. Many will cover Botox for chronic migraines, which have been unresponsive to standard preventative therapies. In 2011, the FDA approved Botox for treating chronic migraines which have been unresponsive to an adequate trial of preventative medications. Preventative medications do not include the use of any narcotic pain killers. Insurance companies have made it difficult for patients to obtain Botox payment authorization, by putting in place numerous qualification barriers – if they cover Botox at all. Insurance compan...
Source: Sarasota Neurology - March 3, 2015 Category: Neurology Authors: Dan Kassicieh, D.O. Tags: Migraines / Headache Boto for headaches Botox covered by insurance botox for headaches Botox Headaches Insurance Source Type: blogs

The March of Legal Settlements Continues into 2015 - Daiichi Sankyo Settles Charges of Kickbacks to Doctors for $39 Million
We are just into January and have our first legal settlement by a major health care corporation of charges of giving physicians kickbacks to spur use of a commercial product.  Like most such stories, this one got little notice.  The most extensive report was in Ed Silverman's PharmaLot blog on the Wall Street Journal site.The Summary and Allegations The basic summary...Daiichi Sankyo agreed to pay $39 million to the U.S. federal government and state Medicaid programs to settle allegations of paying kickbacks to physicians to prescribe several of its drugs. The allegations were ...that Daiichi initiated different ...
Source: Health Care Renewal - January 13, 2015 Category: Health Management Tags: conflicts of interest corporate integrity agreement Daiichi Sankyo impunity kickbacks legal settlements Source Type: blogs

Drip, Drip, Drip - the Steady Accumulation of Little Cases Pointing to Big Problems
Sometimes an apparently insignificant noise can signal a big problem, like the sound of dripping water in a room with no visible plumbing.Today, I noticed a few short stories in the media about one relatively small legal settlement involving a medical device company.  It initially seemed to be too insignificant a settlement to merit a comment.  A closer look, however, suggested links to to other larger issues.  This story reminded me about other apparently small cases that are mostly ignored, but remind us of bigger problems.Biomet Settles Kickback Allegations for $6 Million - the Index CaseHere are the main...
Source: Health Care Renewal - October 31, 2014 Category: Health Management Tags: Arthrocare Baxano Surgical Biomet crime deception Endogastric Solutions fraud Globus Medical impunity Johnson and Johnson kickbacks legal settlements marketing medical devices Nipro Zimmer Source Type: blogs

Can Meditation Help You Become Wolverine?
When I started meditating 7 years or so ago I was reluctant to tell anybody about my guilty little secret, including my family. After all, meditation was weird because how on earth could just sitting quietly achieve anything other than giving you a sore arse and maybe piles? Only strange people meditated. People who wore sandals a lot, stroked whales, raved over recipes using tofu and burned a lot of incense and other assorted legal and not-quite-so-legal herbs. Normal people didn’t meditate. I mean, why on earth would they? Where was the payoff?  Then the research started to trickle in. At first it seemed lik...
Source: Life Coach Blog: The Discomfort Zone : - August 27, 2014 Category: Life Coaches Authors: Tim Brownson Tags: Life Coaching Source Type: blogs

EU To Fine J&J And Novartis Over A Pay-To-Delay Deal
One year after filing a complaint against Johnson & Johnson and Novartis (NVS) - and its Sandoz generic subsidiary - for allegedly conspiring to delay the generic introduction of a prescription drug in the Netherlands, the European Commission is set to fine the drugmakers, Reuters writes. The medicine that has been the subject of their probe is a version of the fentanyl pain patch. A fine has been expected after European antitrust regulators opened their two years ago as part of a widening crackdown on such deals (back story). The concern has picked up steam in recent years as governments attempt to grapple with rising...
Source: Pharmalot - November 25, 2013 Category: Pharma Commentators Authors: esilverman Source Type: blogs

MKSAP: 61-year-old woman with hot flushes
Test your medicine knowledge with the MKSAP challenge, in partnership with the American College of Physicians. A 61-year-old woman is evaluated for hot flushes, which have been persistent for the last 10 years. They occur at least 7 times per day, last for approximately 60 seconds, and are associated with severe sweating, palpitations, and occasional nausea. She is awakened several times per night. She has tried herbal medications, including soy and black cohosh, but has not experienced any benefit. She has hypertension, type 2 diabetes mellitus, and hyperlipidemia. Five years ago, she developed deep venous throm...
Source: Kevin, M.D. - Medical Weblog - November 16, 2013 Category: Family Physicians Tags: Conditions Heart Medications OB/GYN Source Type: blogs

Trip Rapid Review worked example - SSRIs and the management of hot flashes
We reported 0.31 but what does that mean?  I favour trying to assign various narratives based on the score, for instance:1>> 0.5 = Intervention is highly likely to be beneficial.0.49>> 0.25 = Intervention is likely to be beneficial.0.24>> -0.24 = Evidence is weak or ambiguous.-0.25>> -0.49 = Intervention is unlikely to be beneficial.-0.5>> -1 =  Intervention is highly unlikely to be beneficial.But these could be modified based on the number of trials.  For instance scores based on multiple trials is likely to be more reliable than those based on a few.Trip Rapid Reviews is proba...
Source: Liberating the literature - October 2, 2013 Category: Technology Consultants Source Type: blogs

Forest Hires A Fred Hassan Protege To Replace Solomon As CEO
After months of anticipation, Forest Laboratories has finally hired someone to succeed the embattled Howard Solomon. And the winner is… Brent Saunders, a former Schering-Plough exec who has been a Forest director for the past two years and was ceo at Bausch + Lomb, but became available after the eye-care company was purchased by Valeant Pharmaceuticals for $8.7 billion a few months ago. “We have long thought Brent would be an ideal ceo to succeed Howard when the time came. Over the course of our announced search and rigorous board process, during which we seriously evaluated a number of excellent candidates, t...
Source: Pharmalot - September 10, 2013 Category: Pharma Commentators Authors: esilverman Source Type: blogs

Deadly Medicines and Organized Crime by Peter Gøtzsche
'The main reason we take so many drugs is that drug companies don't sell drugs, they sell lies about drugs. This is what makes drugs so different from anything else in life...Virtually everything we know about drugs is what the companies have chosen to tell us and our doctors...the reason patients trust their medicine is that they extrapolate the trust they have in their doctors into the medicines they prescribe. The patients don't realise that, although their doctors may know a lot about diseases and human physiology and psychology, they know very, very little about drugs that hasn't been carefully concocted and...
Source: PharmaGossip - September 1, 2013 Category: Pharma Commentators Authors: insider Source Type: blogs

Q/A – Suggestions from recovery alcoholics and spouses of alcoholics?
You guys might also have this question so I’m posting it here with a good answer too. It comes from ‘MomOf2′ who asks: My husband is a recovering alcoholic of alomst 6 months now. \he’s not the type of alcoholic to drink everyday, he’s a benge drinker. This is the first time that he has been sober this long. Last summer I left him the last time he did it and he moved out of state and I stayed here with our daughter and eventually moved on. As time went by he begged me and begged me to come back to him but I just couldn’t. I didn’t want to live my life like that. Eventually about 6-...
Source: Addiction Recovery Blog - July 15, 2013 Category: Addiction Authors: Addiction Recovery Author Tags: Heroin Treatment Source Type: blogs

Guest blogger Dr. Manuel Mota-Castillo on the overdiagnosis of ADHD
We don't shy away from controversy here at Shrink Rap, and today, child psychiatrist Dr. Mota-Castillo joins us to discuss the idea that children with bipolar disorder are being misdiagnosed with attention deficit disorder and then being inappropriately treated with stimulants, which may be causing them more harm than good.  I've already written about my thoughts on the diagnosis of Bipolar Disorder as a catch-all category, and if you'd like to revisit that, see my article on Rethinking Bipolarity in Clinical Psychiatry News.   And now for our guest blogger: *             *   ...
Source: Shrink Rap - June 28, 2013 Category: Psychiatrists and Psychologists Authors: Dinah Source Type: blogs

Lundbeck Fined $125M Over Pay-To-Delay Deal In Europe
In the latest move by regulators to clamp down on so-called pay-to-delay deals, the European Commission has fined Lundbeck and four other drugmakers for reaching agreements to block entry of generic versions of the best-selling Celexa antidepressant. Lundbeck was fined $125.6 million, while the others - including Ranbaxy Laboratories - paid a total of nearly $70 million. After the basic patent that Lundbeck held on the molecule had expired, the drugmaker only retained a number of related process patents that provided limited protection. And so, Lundbeck struck deals in 2002 with generic rivals to refrain from selling copyc...
Source: Pharmalot - June 19, 2013 Category: Pharma Commentators Authors: esilverman Source Type: blogs

EU fines Lundbeck for paying off pharma rivals
The European Commission has fined Danish pharmaceutical Lundbeck €93.8 million after the EU executive ruled that it had paid rival companies to delay market entry of generic versions of anti-depressant Citalopram. Prices of Citalopram fell by 90% when cheaper generic versions of the drug became widely available. http://euobserver.com/tickers/120551? (Source: PharmaGossip)
Source: PharmaGossip - June 19, 2013 Category: Pharma Commentators Authors: insider Source Type: blogs

Lundbeck Faces 'Sizeable' Fine Over Pay-To-Delay Deals In Europe
Nearly a year after charging nine drugmakers - including Lundbeck, Merck KGgA and Ranbaxy Laboratories - with blocking the entry of generic versions of the best-selling Celexa antidepressant, the European Commission is getting ready to hand out fines, Reuters reports. Last July, the EC charged Lundbeck and its rivals struck deals that "foresaw substantial value transfers" to the generic competitors, which subsequently did not sell lower-cost versions of the antidepressant. These value transfers included direct payments from Lundbeck to the other drugmakers, well as purchases of generic Celexa stock for destructio...
Source: Pharmalot - June 3, 2013 Category: Pharma Commentators Authors: esilverman Source Type: blogs

Forest CEO Solomon Finally Listens To Carl Icahn And Will Retire
Carl Icahn has been waiting a long time for this. After years of controversy over his stewardship, Howard Solomon will retire as ceo of Forest Laboratories by the end of the year, and he will relinquish his role as chairman by the time the drugmaker holds its annual meeting in 2014. Meanwhile, a committee has been appointed to choose a successor. He will, however, remain a director. The move comes after Solomon, who is 85 and has been ceo since 1977, has had a decidedly mixed tenure. On one hand, he helped build the drugmaker into a large purveyor of medicines, but more recently, he presided over setbacks that prompted cor...
Source: Pharmalot - May 23, 2013 Category: Pharma Commentators Authors: esilverman Source Type: blogs

Citalopram in the Sunday Post
Reblogged from Leonie fennell's Blog: I never expected my life to turn out like this. Before Shane died, I was happily rambling along minding my own business (I was, I swear!). There are more and more compelling arguments that Citalopram and other SSRIs can cause people to kill themselves and others. Don't let it be you or your family. Be aware that these type of drugs are powerful mind altering drugs. Read more… 125 more words (Source: Dawn Willis sharing the News and Views of the Mentally Wealthy)
Source: Dawn Willis sharing the News and Views of the Mentally Wealthy - May 8, 2013 Category: Mental Illness Authors: Dawn Willis Tags: Mental Health, The News & Policies. Source Type: blogs

The Myth of the Tough Prosecutor as a Distraction from Health Care Corporate Executives' Impunity
The tragic case of the Boston Marathon bombing illustrates how myth making about tough law enforcement obscures the impunity enjoyed by top health care executives. A "Tough to a Fault" ProsecutorA recent Reuters article touted the toughness of the prosecutor who will take on the case of the surviving accused Boston terrorist:As the top federal law enforcer in Massachusetts, U.S. Attorney Carmen Ortiz has taken heat for being tough to a fault and coming down too hard on some defendants. But as she builds a possible death penalty case against suspected Boston Marathon bomber Dzhokhar Tsarnaev, 19, the unflinch...
Source: Health Care Renewal - April 25, 2013 Category: Health Medicine and Bioethics Commentators Tags: US Department of Justice impunity legal settlements public relations Source Type: blogs

Medications that Increase the Risks of Patient Falls
Falls are the leading cause of both fatal and non-fatal injuries for adults 65 and older. Alzheimer's Reading Room “Falls are the leading cause of both fatal and non-fatal injuries for adults 65 and older, and research suggests that those taking four or more medications are at an even greater risk than those who don’t – perhaps two to three times greater,” said Susan Blalock, Ph.D., an associate professor at the UNC Eshelman School of Pharmacy. In 2007, more than 21,700 Americans died as a result of falls and more than 7.9 million were injured by a fall including over 1.8 million older adults who...
Source: Alzheimer's Reading Room, The - February 14, 2013 Category: Dementia Authors: Bob DeMarco Source Type: blogs

Withdrawal from Psychiatric Meds Can Be Painful, Lengthy
This article was edited to clarify a few sentences on Feb. 14, 2013.   References Kotzalidis, G.D. et al. (2007). The adult SSRI/SNRI withdrawal syndrome: A clinically heterogeneous entity. Clinical Neuropsychiatry: Journal of Treatment Evaluation, 4, 61-75. Nielsen, M., Hansen, E.H., & Gøtzsche, P.C. (2012). What is the difference between dependence and withdrawal reactions? A comparison of benzodiazepines and selective serotonin re-uptake inhibitors. Addiction, 107, 900-908. Therrien, F. & Markowitz, J.S. (1997). Selective serotonin reuptake inhibitors and withdrawal symptoms: A review of the literatu...
Source: World of Psychology - February 13, 2013 Category: Psychiatrists and Psychologists Authors: John M. Grohol, PsyD Tags: Antidepressant Antipsychotic General Medications Policy and Advocacy Psychiatry Research Treatment Caffeine Stimulants Celexa Cymbalta Discontinuation Fluoxetine Hand Experience Hyperactivity Illicit Drugs Lengthy Time Le Source Type: blogs

EU Charges J&J And Novartis With Pay-To-Delay
In the latest bid by regulators to squash so-called pay-to-delay deals, the European Commission has filed a complaint against Johnson & Johnson and Novartis – and its Sandoz generic subsidiary – for allegedly conspiring to delay the generic introduction of a version of the fentanyl pain patch in the Netherlands. The move had been expected after European antitrust regulators opened a probe into the drugmakers in October 2011 as part of a widening crackdown on such deals (back story). The concern has picked up steam in recent years as governments attempt to grapple with rising healthcare costs and investigato...
Source: Pharmalot - January 31, 2013 Category: Pharma Commentators Authors: Ed Silverman Tags: Uncategorized AARP American Medical Association Antitrust FTC Generics JJ Johnson & Johnson Lundbeck Merck KgGA Novartis Pay-To-Delay Ranbaxy Laboratories Sandoz Teva Pharmaceuticals Source Type: blogs

EU Charges J&J And Novartis With Pay-To-Delay // Pharmalot
In the latest bid by regulators to squash so-called pay-to-delay deals, the European Commission has filed a complaint against Johnson & Johnson and Novartis – and its Sandoz generic subsidiary – for allegedly conspiring to delay the generic introduction of a version of the fentanyl pain patch in the Netherlands. The move had been expected after European antitrust regulators opened a probe into the drugmakers in October 2011 as part of a widening crackdown on such deals (back story). The concern has picked up steam in recent years as governments attempt to grapple with rising healthcare costs and investigato...
Source: PharmaGossip - January 31, 2013 Category: Pharma Commentators Authors: insider Source Type: blogs

Top stories in health and medicine, January 30, 2013
This series is brought to you by MedPage Today.1. Some SSRIs Tied to Heart Rhythm Problems. Citalopram and two other antidepressants were associated with prolongation of corrected QT interval — a marker of increased ventricular arrhythmia risk.2. RUC Targeted at Senate Hearing on Primary Care. The nation’s primary care physician (PCP) shortage might be eased by requiring more transparency from the group that helps set Medicare pay rates.3. Combo Therapy Shines in Colon Cancer. First-line combination bevacizumab and capecitabine therapy may be an optimal first-line treatment for metastatic colorectal cancer in t...
Source: Kevin, M.D. - Medical Weblog - January 30, 2013 Category: Family Physicians Tags: Meds Cancer Heart Psychiatry Source Type: blogs

#Citalopram and #Escitalopram confirmed as triggering a heart rhythm disturbance. #MentalHealth #ukmh #Depression
Click for the article Filed under: Mental Health, The News & Policies. (Source: Dawn Willis sharing the News and Views of the Mentally Wealthy)
Source: Dawn Willis sharing the News and Views of the Mentally Wealthy - January 30, 2013 Category: Mental Illness Authors: Dawn Willis Tags: Mental Health, The News & Policies. Source Type: blogs

Popular Antidepressants May Put Patients At Risk For Serious Arrhythmias
In August 2011 the FDA issued a safety communication recommending that the extremely popular antidepressant citalopram (Celexa) not be used at doses greater than 40 mg/day because of a potential increased risk for serious cardiac arrhythmias associated with prolongation of the QT interval. Now a study published in BMJ lends support to this warning and suggests that other antidepressants may also prolong the QT interval. Click here to read the complete story on Forbes.   (Source: CardioBrief)
Source: CardioBrief - January 29, 2013 Category: Cardiology Authors: Larry Husten Tags: Uncategorized Antidepressant BMJ Citalopram FDA food and drug administration Selective serotonin reuptake inhibitor Source Type: blogs

Finding Back My ‘Margaret-Ness’ by Margaret Franklin
The other night my husband and I saw the movie �You, me and DuPree and the more I think about it, the more I find myself relating to the character of DuPree and thinking that he, too, definitely had some �Aspie-ish� traits. Not all Aspies are shy, introverted bookworms. In fact many of us are also quite bouncy, sociable and outgoing, very much like DuPree, who often spoke his mind and got himself into some pretty awkward situations by basically diving head-first into everything. Although he could not get a job and his actions often got him into trouble, DuPree had some very interesting and wonderful gifts and talents...
Source: The Autism Acceptance Project - January 18, 2013 Category: Autism Authors: ADTP Tags: Autspoken Source Type: blogs

The Tragic Case of Aaron Swartz: Unequal Justice for Web Activists vs Health Care Corporate Executives
The recent tragic case of the suicide of Aaron Swartz raises many issues, and has inspired an outpouring of news coverage and internet discussion.  Yet one issue it should raise that has not received much notice so far is that of how individuals and top executives are treated differently before the law.Summary of the CaseAaron Swartz was a prodigy who developed  helped develop the RSS system for disseminating updates on web-site contents, and who helped develop the Reddit web-site.  He was an advocate for information freedom, and more broadly, according to Matt Stoller, "a political activist interested ...
Source: Health Care Renewal - January 15, 2013 Category: Health Medicine and Bioethics Commentators Tags: US Department of Justice impunity Forest Pharmaceuticals legal settlements St Jude Medical GlaxoSmithKline Source Type: blogs

Q/A – Am I in depression denial? Read explanation?
You guys might also have this question so I’m posting it here with a good answer too. It comes from ‘Audie89′ who asks: I’m 22 years old, and until I was 18…my social skills were painfully awkward. Finally, however, I came out of my shell. I got into the nightclub/rave scene and began working as a promoter for the biggest nightclub in the US while attending a university. I had tons of friends, I dated some gorgeous girls, and I loved going out and having a good time. Life was good. After 1 1/2 years, however, I started getting into prescription painkillers (namely oxycodone). I was in way ove...
Source: Addiction Recovery Blog - January 10, 2013 Category: Addiction Authors: Addiction Recovery Author Tags: Opiate Treatment Source Type: blogs